People · Operator
Named in public records as an officer, director or promoter · active 2018–2025 · Biotechnology, Other, Healthtech, Software / Tech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Delfi Diagnostics, Inc. | — | Biotechnology | Series D+ | $365.9M | $235.7M | 2019 |
| H1 Insights, Inc. | — | Other | Series D+ | $271.0M | $844.6M | 2020 |
| Clear Labs, Inc. | — | Biotechnology | Series C | $135.8M | $218.3M | 2018 |
| Ophelia Health, Inc. | — | Healthtech | Series C | $68.4M | $859.3M | 2021 |
| Particle Health Inc. | — | Healthtech | Series B | $38.3M | $311.3M | 2020 |
| Cartwheel Care Inc. | — | Healthtech | Series B | $35.2M | $168.0M | 2025 |
| Vital Labs, Inc. | — | Software / Tech | Series A | $23.7M | $83.5M | 2020 |
| Koala Health, Inc. | — | Healthtech | Series B | $20.0M | $265.9M | 2022 |
Greg Yap at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Greg Yap on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Josh Kopelman | 1 | 14 |
| Adam D'Augelli | 1 | 13 |
| Rebecca Lynn | 1 | 12 |
| Gaurav Garg | 1 | 12 |
| Rishi Gupta | 1 | 12 |
| Taylor Greene | 1 | 9 |
| Mostafa Ronaghi | 1 | 8 |
| Somesh Dash | 1 | 8 |
| Holly Maloney | 1 | 7 |
| Michael Taylor | 1 | 7 |
| Farzad Naimi | 1 | 5 |
| Steve Kupfer | 1 | 5 |
| MICHAEL DYBBS | 1 | 5 |
| Elton Satusky | 1 | 4 |
| Ming Fang | 1 | 4 |
| Justin Kao | 1 | 4 |
| Kazutaka Ohno | 1 | 4 |
| Brian Hogan | 1 | 4 |
| William Stevens | 1 | 3 |
| Doug Barry | 1 | 3 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.